Scherings pegylated interferon approved for treating hepatitis C in HIV coinfected patients
3 July 2007. Related: Hepatitis coinfection.
2007
Campaign launched for HIV-positive people denied access to stay in the UK
3 July 2007. Related: Other news.
Meeting abstracts and reports
3 July 2007. Related: On the web.
Journal articles and online resources
3 July 2007. Related: On the web.
Volume 8 Number 6/7 June/July 2007 PDF
1 July 2007. Related: PDFs.
Volume 8 Number 5 May 2007
30 May 2007. Related: Editorial.
14th Conference on Retroviruses and Opportunistic Infections, 25-28 February 2007, Los Angeles
5 May 2007. Related: Conference reports.
No benefit of early cessation of breastfeeding in the Zambia Exclusive Breastfeeding Study (ZEBS)
4 May 2007. Related: Conference reports, Pregnancy.
Role of infant feeding and HIV in a severe diarrhoea outbreak in Botswana
4 May 2007. Related: Conference reports, Pregnancy.
Diarrhoea in uninfected infants of HIV-positive mothers who stop breastfeeding at 6 Months
4 May 2007. Related: Conference reports, Pregnancy.
Post-weaning gastroenteritis and mortality in HIV-uninfected infants receiving antiretroviral prophylaxis
4 May 2007. Related: Conference reports, Pregnancy.
Rates of diarrhoea associated with early weaning among infants in the Kisumu breastfeeding study
4 May 2007. Related: Conference reports, Pregnancy.
Early breastfeeding cessation among infants and risk of serious gastroenteritis: findings from a perinatal prevention trial in Kampala, Uganda
4 May 2007. Related: Conference reports, Pregnancy.
Treating children in resource-limited settings
4 May 2007. Related: Conference reports, Paediatric care.
Pharmacokinetics of nevirapine, d4T, and 3TC in Zambian children treated with Pedimune (Triomune)
4 May 2007. Related: Conference reports, Paediatric care.
New PK data for protease inhibitors
4 May 2007. Related: Conference reports, Treatment access, Paediatric care, Guidelines.
Plasma concentrations of efavirenz and lopinavir in children with and without rifampicin-based TB treatment
4 May 2007. Related: Conference reports, Paediatric care, TB coinfection.
NNRTI vs PI HAART regimens for children in resource-limited settings
4 May 2007. Related: Conference reports, Paediatric care.
Predictors of infant mortality
4 May 2007. Related: Conference reports, Paediatric care.
HIV-infection in the brain, neurocognitive dysfunction and CNS drug penetration
4 May 2007. Related: Conference reports.
Selected genetics studies from CROI
4 May 2007. Related: Conference reports.
Report from genomics workshop at CROI
4 May 2007. Related: Conference reports.
5th European HIV Drug Resistance Workshop, Cascais, Portugal, 29 March 2007
4 May 2007. Related: Conference reports.
Few integrase inhibitor (INI) mutations in INI-naive people
4 May 2007. Related: Conference reports, Drug resistance.
Response to darunavir, tipranavir, or lopinavir after atazanavir failure
4 May 2007. Related: Conference reports, Drug resistance.
Upper and lower clinical cutoffs proposed for darunavir
4 May 2007. Related: Conference reports, Drug resistance.
Accuracy of Monograms Trofile assay in determining tropism and new tropism assays in development
4 May 2007. Related: Conference reports, Drug resistance.
Several genotyping systems offer hope as tropism predictors
4 May 2007. Related: Conference reports, Drug resistance.
Clinton Foundation announces significant price reductions for generic second-line drug and more tolerable first-line options
4 May 2007. Related: Treatment access.
Generic tenofovir licensed in South Africa
4 May 2007. Related: Treatment access.
Agreement for generic license of darunavir in South Africa
4 May 2007. Related: Treatment access.
Brazil issues plans to produce generic efavirenz
4 May 2007. Related: Treatment access.
Access to Abbott drugs in Thailand
4 May 2007. Related: Treatment access.
Indian government only plans to provide access to second-line ARVs after first-line drug treatment targets are met
4 May 2007. Related: Treatment access.
Increasing antiretroviral access for children
4 May 2007. Related: Treatment access, Paediatric care.
HIV-positive women and drug and alcohol use
4 May 2007. Related: On the web.
WHO Bulletin: TB special issue
4 May 2007. Related: On the web.
Full free access online journal articles
3 May 2007. Related: On the web.
Volume 8 Number 5 May 2007 PDF
1 May 2007. Related: PDFs.
Volume 8 Number 3/4 March/April 2007
29 April 2007. Related: Editorial.
14th Conference on Retroviruses and Opportunistic Infections, 25-28 February 2007, Los Angeles
24 April 2007. Related: Conference reports.
Raltegravir (MK-0518) phase 3 trials show successful viral suppression in multi-drug resistant patients
4 April 2007. Related: Conference reports, Antiretrovirals, Drug resistance.
Maraviroc phase 2b/3 results in treatment experienced CCR5-tropic patients
4 April 2007. Related: Conference reports, Antiretrovirals.
Phase 2 study of Gileads integrase inhibitor elvitegravir (GS-9137)
4 April 2007. Related: Conference reports, Antiretrovirals.
Phase 2b study comparing rilpivirine (TMC-278) to efavirenz in treatment-naive patients: 48-week results
4 April 2007. Related: Conference reports, Antiretrovirals.
PK results from heat-stable formulation of ritonavir
4 April 2007. Related: Conference reports, Antiretrovirals.
Use of low-dose rapamycin, a CCR5 suppressant, to increase potency of T-20 in vitro
4 April 2007. Related: Conference reports, Antiretrovirals.
Growth hormone release factor (TH9507) reduces central fat adiposity
4 April 2007. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Further insight into risk and management of cardiovascular disease (CVD) from D:A:D cohort: no additional benefit of metabolic syndrome diagnosis; new HIV-specific CVD risk equations; increasing uptake of lipid lowering drugs but low smoking cessation
4 April 2007. Related: Conference reports, Side effects.
Pregnancy outcomes in the DART trial
4 April 2007. Related: Conference reports, Pregnancy.
12 month response to HAART in women following exposure to prevention of mother to child transmission regimens
4 April 2007. Related: Conference reports, Pregnancy.
Unexpectedly high rate of K65R mutation in patients failing first-line d4T-containing regimens in Thailand
4 April 2007. Related: Conference reports, Drug resistance.
Sexual transmission of HCV in Brighton reported in HIV positive and HIV negative MSM
4 April 2007. Related: Conference reports, Hepatitis coinfection.
Hepatitis B drug entecavir reported to have anti-HIV viral activity in three patients
4 April 2007. Related: Conference reports, Hepatitis coinfection.
High 6-month rate of PML survival with aggressive use of 5-drug T-20-based ARV regimen
4 April 2007. Related: Conference reports, Coinfections and complications.
Increased anal HPV levels in HV-positive smokers
4 April 2007. Related: Conference reports, Cancer and HIV.
Clade-B HIV-1 infection in Haiti predates global subtype-B virus
4 April 2007. Related: Conference reports.
Drug interactions and pharmacokinetic studies: CROI 2007
4 April 2007. Related: Conference reports, PK and drug interactions.
Darunavir (TMC-114) approved in Europe
4 April 2007. Related: Antiretrovirals.
No significant interaction reported between etravirine (TMC125) and raltegravir (MK-0518)
4 April 2007. Related: Antiretrovirals.
Future of second-generation fusion inhibitors less certain as Trimeris and Roche separate
4 April 2007. Related: Antiretrovirals.
Abbott situation worsens in Thailand
4 April 2007. Related: Treatment access.
BHIVA launch standards for HIV clinical care (2007)
4 April 2007. Related: Guidelines.
Use of scientific evidence in criminal prosecutions for HIV transmission
4 April 2007. Related: On the web.
Articles from AIDS and Medscape
4 April 2007. Related: On the web.